Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty

BACKGROUND: The study aimed to report the outcomes of patients treated with cenegermin 0.002% for neurotrophic keratopathy (NK) following penetrating keratoplasty (PK). MATERIALS AND METHODS: This retrospective case series included patients evaluated at a tertiary care hospital who completed an 8-we...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexandra R. Zaloga, Ashley Khalili, Brandon D. Ayres, Brenton D. Finklea, Beeran B. Meghpara, Christopher J. Rapuano, Zeba A. Syed
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2025-05-01
coleção:	Oman Journal of Ophthalmology
Assuntos:	cenegermin neurotrophic keratopathy penetrating keratoplasty
Acesso em linha:	https://journals.lww.com/10.4103/ojo.ojo_311_24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!